| Dr Michael Raymond Watts, DO | |
|
19600 E 39th St S, Independence, MO 64057-2301 | |
| (816) 698-7000 | |
| Not Available |
| Full Name | Dr Michael Raymond Watts |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Experience | 16 Years |
| Location | 19600 E 39th St S, Independence, Missouri |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1639342819 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 2012014551 (Missouri) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Golden Valley Memorial Hospital | Clinton, MO | Hospital |
| St Marys Medical Center | Blue springs, MO | Hospital |
| Saint John Hospital | Leavenworth, KS | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Blue Springs Emergency Physicians Llc | 0749692861 | 6 |
News Archive
The Denver Post: "Nearly 14,000 Coloradans are losing their form of Medicare Advantage plans next year and will need to choose new options, creating a hardship for 1,700 rural Medicare members who won't find similar plans left on the table. Medicare Advantage carriers such as Humana, Anthem, Secure Horizons and MVP dropped some Medicare Advantage plans in Colorado. … The dropped carriers affect 13,936 beneficiaries in Colorado, including 3,832 in the Denver metro area" (Booth, 12/2).
The coronavirus disease (COVID-19) has rippled across the world with a devastating effect. As scientists raced to find an effective treatment for patients, existing malaria and rheumatoid arthritis drug hydroxychloroquine became one of the most popular candidates.
More than 33 percent of eligible Washington residents have signed up for care on the state's health law online insurance exchange. In New York and California, exchanges see big sign-up numbers. Finally, lawmakers in Florida and Virginia ready plans for insurance exchanges that aren't part of the health law.
An Indiana University study found that after a countywide smoking ban was implemented, hospital admissions for such heart attacks dropped 70 percent for non-smokers - but not for smokers.
Jennerex, Inc., a clinical-stage cancer biotherapeutics company, today announced that it has completed patient enrollment in a Phase 1 clinical trial evaluating the intravenous (IV) administration of JX-594, the company's lead product for the treatment of solid tumors. Jennerex expects to report the results from this trial at the American Society of Gene and Cell Therapy (ASGCT) Annual Meeting in May 2010.
› Verified 2 days ago
| Entity Name | Midwest Division - Lrhc Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1639362460 PECOS PAC ID: 0941119150 Enrollment ID: O20031105000738 |
News Archive
The Denver Post: "Nearly 14,000 Coloradans are losing their form of Medicare Advantage plans next year and will need to choose new options, creating a hardship for 1,700 rural Medicare members who won't find similar plans left on the table. Medicare Advantage carriers such as Humana, Anthem, Secure Horizons and MVP dropped some Medicare Advantage plans in Colorado. … The dropped carriers affect 13,936 beneficiaries in Colorado, including 3,832 in the Denver metro area" (Booth, 12/2).
The coronavirus disease (COVID-19) has rippled across the world with a devastating effect. As scientists raced to find an effective treatment for patients, existing malaria and rheumatoid arthritis drug hydroxychloroquine became one of the most popular candidates.
More than 33 percent of eligible Washington residents have signed up for care on the state's health law online insurance exchange. In New York and California, exchanges see big sign-up numbers. Finally, lawmakers in Florida and Virginia ready plans for insurance exchanges that aren't part of the health law.
An Indiana University study found that after a countywide smoking ban was implemented, hospital admissions for such heart attacks dropped 70 percent for non-smokers - but not for smokers.
Jennerex, Inc., a clinical-stage cancer biotherapeutics company, today announced that it has completed patient enrollment in a Phase 1 clinical trial evaluating the intravenous (IV) administration of JX-594, the company's lead product for the treatment of solid tumors. Jennerex expects to report the results from this trial at the American Society of Gene and Cell Therapy (ASGCT) Annual Meeting in May 2010.
› Verified 2 days ago
| Entity Name | Ascentist Physicians Group Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1649206319 PECOS PAC ID: 9335143759 Enrollment ID: O20060826000062 |
News Archive
The Denver Post: "Nearly 14,000 Coloradans are losing their form of Medicare Advantage plans next year and will need to choose new options, creating a hardship for 1,700 rural Medicare members who won't find similar plans left on the table. Medicare Advantage carriers such as Humana, Anthem, Secure Horizons and MVP dropped some Medicare Advantage plans in Colorado. … The dropped carriers affect 13,936 beneficiaries in Colorado, including 3,832 in the Denver metro area" (Booth, 12/2).
The coronavirus disease (COVID-19) has rippled across the world with a devastating effect. As scientists raced to find an effective treatment for patients, existing malaria and rheumatoid arthritis drug hydroxychloroquine became one of the most popular candidates.
More than 33 percent of eligible Washington residents have signed up for care on the state's health law online insurance exchange. In New York and California, exchanges see big sign-up numbers. Finally, lawmakers in Florida and Virginia ready plans for insurance exchanges that aren't part of the health law.
An Indiana University study found that after a countywide smoking ban was implemented, hospital admissions for such heart attacks dropped 70 percent for non-smokers - but not for smokers.
Jennerex, Inc., a clinical-stage cancer biotherapeutics company, today announced that it has completed patient enrollment in a Phase 1 clinical trial evaluating the intravenous (IV) administration of JX-594, the company's lead product for the treatment of solid tumors. Jennerex expects to report the results from this trial at the American Society of Gene and Cell Therapy (ASGCT) Annual Meeting in May 2010.
› Verified 2 days ago
| Entity Name | Blue Springs Emergency Physicians Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1841897261 PECOS PAC ID: 0749692861 Enrollment ID: O20201215000999 |
News Archive
The Denver Post: "Nearly 14,000 Coloradans are losing their form of Medicare Advantage plans next year and will need to choose new options, creating a hardship for 1,700 rural Medicare members who won't find similar plans left on the table. Medicare Advantage carriers such as Humana, Anthem, Secure Horizons and MVP dropped some Medicare Advantage plans in Colorado. … The dropped carriers affect 13,936 beneficiaries in Colorado, including 3,832 in the Denver metro area" (Booth, 12/2).
The coronavirus disease (COVID-19) has rippled across the world with a devastating effect. As scientists raced to find an effective treatment for patients, existing malaria and rheumatoid arthritis drug hydroxychloroquine became one of the most popular candidates.
More than 33 percent of eligible Washington residents have signed up for care on the state's health law online insurance exchange. In New York and California, exchanges see big sign-up numbers. Finally, lawmakers in Florida and Virginia ready plans for insurance exchanges that aren't part of the health law.
An Indiana University study found that after a countywide smoking ban was implemented, hospital admissions for such heart attacks dropped 70 percent for non-smokers - but not for smokers.
Jennerex, Inc., a clinical-stage cancer biotherapeutics company, today announced that it has completed patient enrollment in a Phase 1 clinical trial evaluating the intravenous (IV) administration of JX-594, the company's lead product for the treatment of solid tumors. Jennerex expects to report the results from this trial at the American Society of Gene and Cell Therapy (ASGCT) Annual Meeting in May 2010.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Michael Raymond Watts, DO 16529 Barton St, Overland Park, KS 66062-7531 Ph: (913) 766-6061 | Dr Michael Raymond Watts, DO 19600 E 39th St S, Independence, MO 64057-2301 Ph: (816) 698-7000 |
News Archive
The Denver Post: "Nearly 14,000 Coloradans are losing their form of Medicare Advantage plans next year and will need to choose new options, creating a hardship for 1,700 rural Medicare members who won't find similar plans left on the table. Medicare Advantage carriers such as Humana, Anthem, Secure Horizons and MVP dropped some Medicare Advantage plans in Colorado. … The dropped carriers affect 13,936 beneficiaries in Colorado, including 3,832 in the Denver metro area" (Booth, 12/2).
The coronavirus disease (COVID-19) has rippled across the world with a devastating effect. As scientists raced to find an effective treatment for patients, existing malaria and rheumatoid arthritis drug hydroxychloroquine became one of the most popular candidates.
More than 33 percent of eligible Washington residents have signed up for care on the state's health law online insurance exchange. In New York and California, exchanges see big sign-up numbers. Finally, lawmakers in Florida and Virginia ready plans for insurance exchanges that aren't part of the health law.
An Indiana University study found that after a countywide smoking ban was implemented, hospital admissions for such heart attacks dropped 70 percent for non-smokers - but not for smokers.
Jennerex, Inc., a clinical-stage cancer biotherapeutics company, today announced that it has completed patient enrollment in a Phase 1 clinical trial evaluating the intravenous (IV) administration of JX-594, the company's lead product for the treatment of solid tumors. Jennerex expects to report the results from this trial at the American Society of Gene and Cell Therapy (ASGCT) Annual Meeting in May 2010.
› Verified 2 days ago
Thomas R Coughlin Jr., MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 1509 W Truman Rd, Emergency Department, Independence, MO 64050 Phone: 913-469-4244 Fax: 913-469-1939 | |
David R. Gustafson, DO Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 3507 Shady Bend Dr, Independence, MO 64052 Phone: 816-651-8631 | |
Dr. Allison Janell Barfuss-walter, D.O. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 19600 E 39th St S, Independence, MO 64057 Phone: 816-698-7000 Fax: 816-698-7000 | |
Aulton Dale Chisum, DO Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 1509 W Truman Rd, Emergency Department, Independence, MO 64050 Phone: 913-469-1488 Fax: 913-469-1441 | |
Harry E Kleiner, DO Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1509 W Truman Rd, Emergency Department, Independence, MO 64050 Phone: 913-469-4244 Fax: 913-469-1939 | |
Aryn Elizabeth Dixon, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 19600 E 39th St S, Independence, MO 64057 Phone: 816-698-7000 |